MicroRNAs (miRNAs) are small non-coding RNAs (~22 nucleotides) that regulate gene expression by binding to messenger RNA (mRNA) and promoting degradation or translational inhibition. They are key regulators in gene expression networks and have shown promise as biomarkers for disease. Advances in technology have enabled various platforms for miRNA profiling, and understanding their strengths and limitations is crucial for effective use in diverse applications. This review discusses the major considerations for conducting and interpreting miRNA profiling studies, as well as current and emerging applications. MiRNAs are stable in various specimen types, including blood plasma, serum, and formalin-fixed tissues, and are more sensitive than proteins. They are widely used in disease biomarker studies, including cancers, cardiovascular diseases, and autoimmune disorders. MiRNA profiling is also applied in forensic analysis and stem cell research. The review covers the characteristics of miRNAs, including their biogenesis, stability, and diversity, and discusses challenges in their detection and quantification. Various methods for miRNA profiling include quantitative reverse transcription-PCR (qRT-PCR), hybridization-based methods (e.g., microarrays), and RNA sequencing (RNA-seq). Each method has its strengths and limitations, with qRT-PCR being highly sensitive and suitable for absolute quantification, microarrays being cost-effective for relative abundance analysis, and RNA-seq providing comprehensive data on miRNA expression and novel miRNAs. Applications of miRNA profiling include understanding gene regulation, identifying disease biomarkers, and studying miRNA-mRNA and miRNA-protein interactions. MiRNA profiling has been used to identify biomarkers for diseases such as cancer, multiple sclerosis, and rheumatoid arthritis. It is also used in forensic analysis and for studying developmental biology and stem cell biology. The review emphasizes the importance of proper sample processing, RNA extraction, and data analysis in miRNA profiling. It highlights the need for quality control, normalization, and validation of results. Future directions include the integration of miRNA profiling with other genomic data and the development of more sensitive and cost-effective methods for miRNA detection and analysis. Overall, miRNA profiling is a valuable tool for understanding biological processes and has significant potential for clinical applications.MicroRNAs (miRNAs) are small non-coding RNAs (~22 nucleotides) that regulate gene expression by binding to messenger RNA (mRNA) and promoting degradation or translational inhibition. They are key regulators in gene expression networks and have shown promise as biomarkers for disease. Advances in technology have enabled various platforms for miRNA profiling, and understanding their strengths and limitations is crucial for effective use in diverse applications. This review discusses the major considerations for conducting and interpreting miRNA profiling studies, as well as current and emerging applications. MiRNAs are stable in various specimen types, including blood plasma, serum, and formalin-fixed tissues, and are more sensitive than proteins. They are widely used in disease biomarker studies, including cancers, cardiovascular diseases, and autoimmune disorders. MiRNA profiling is also applied in forensic analysis and stem cell research. The review covers the characteristics of miRNAs, including their biogenesis, stability, and diversity, and discusses challenges in their detection and quantification. Various methods for miRNA profiling include quantitative reverse transcription-PCR (qRT-PCR), hybridization-based methods (e.g., microarrays), and RNA sequencing (RNA-seq). Each method has its strengths and limitations, with qRT-PCR being highly sensitive and suitable for absolute quantification, microarrays being cost-effective for relative abundance analysis, and RNA-seq providing comprehensive data on miRNA expression and novel miRNAs. Applications of miRNA profiling include understanding gene regulation, identifying disease biomarkers, and studying miRNA-mRNA and miRNA-protein interactions. MiRNA profiling has been used to identify biomarkers for diseases such as cancer, multiple sclerosis, and rheumatoid arthritis. It is also used in forensic analysis and for studying developmental biology and stem cell biology. The review emphasizes the importance of proper sample processing, RNA extraction, and data analysis in miRNA profiling. It highlights the need for quality control, normalization, and validation of results. Future directions include the integration of miRNA profiling with other genomic data and the development of more sensitive and cost-effective methods for miRNA detection and analysis. Overall, miRNA profiling is a valuable tool for understanding biological processes and has significant potential for clinical applications.